Study S002239

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS-7535 for the Treatment of Hypertension in Participants With Obesity or Overweight

ClinicalTrials.gov record

Registration

Registration: NCT07528027
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 648
Start: 2026-05-29
Primary completion: 2027-12
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Hypertension With Overweight or Obesity
Interventions: DRUG:HRS-7535; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Change in SBP relative to baseline at Week 24 [at Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.